MetLife Inc. (NYSE:MET) – Stock analysts at FBR & Co lowered their Q3 2016 earnings per share estimates for MetLife in a research note issued to investors on Tuesday. FBR & Co analyst R. Binner now expects that the brokerage will earn $1.15 per share for the quarter, down from their prior forecast of $1.33. FBR & Co currently has a “Outperform” rating and a $54.00 target price on the stock. FBR & Co also issued estimates for MetLife’s FY2016 earnings at $4.50 EPS and FY2017 earnings at $5.50 EPS.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by $0.52. The firm had revenue of $17 billion for the quarter, compared to analyst estimates of $17.35 billion. MetLife had a return on equity of 6.18% and a net margin of 6.49%. The company’s quarterly revenue was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.56 earnings per share.

Earnings History and Estimates for MetLife (NYSE:MET)

Other equities research analysts have also recently issued reports about the company. Zacks Investment Research upgraded MetLife from a “sell” rating to a “hold” rating in a research note on Thursday, July 7th. Argus reiterated a “buy” rating and set a $54.00 target price on shares of MetLife in a research note on Wednesday, September 7th. Deutsche Bank AG cut MetLife from a “buy” rating to a “hold” rating and lowered their target price for the stock from $47.00 to $44.00 in a research note on Wednesday, July 13th. Citigroup Inc. lowered their target price on MetLife from $46.00 to $42.00 and set a “neutral” rating on the stock in a research note on Thursday, July 7th. Finally, Evercore ISI began coverage on MetLife in a research note on Wednesday, July 6th. They issued a “buy” rating and a $52.00 price objective on the stock. Eight investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company. MetLife presently has a consensus rating of “Buy” and an average price target of $51.95.

Shares of MetLife (NYSE:MET) traded up 0.32% during midday trading on Wednesday, reaching $46.95. 2,284,468 shares of the company’s stock were exchanged. The company has a market cap of $51.59 billion, a P/E ratio of 12.34 and a beta of 1.84. The firm has a 50 day moving average price of $44.78 and a 200 day moving average price of $43.27. MetLife has a 12 month low of $35.00 and a 12 month high of $52.45.

In other MetLife news, EVP Maria R. Morris sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $42.96, for a total value of $85,920.00. Following the completion of the sale, the executive vice president now owns 109,273 shares of the company’s stock, valued at $4,694,368.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Maria R. Morris sold 8,800 shares of the company’s stock in a transaction that occurred on Tuesday, October 4th. The stock was sold at an average price of $45.00, for a total value of $396,000.00. Following the completion of the sale, the executive vice president now directly owns 116,409 shares of the company’s stock, valued at approximately $5,238,405. The disclosure for this sale can be found here. 0.27% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in MET. Vanguard Group Inc. increased its stake in shares of MetLife by 2.0% in the second quarter. Vanguard Group Inc. now owns 59,800,082 shares of the company’s stock valued at $2,381,837,000 after buying an additional 1,191,274 shares during the last quarter. Dodge & Cox increased its stake in shares of MetLife by 26.4% in the second quarter. Dodge & Cox now owns 39,133,326 shares of the company’s stock valued at $1,558,680,000 after buying an additional 8,185,247 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of MetLife by 10.1% in the second quarter. JPMorgan Chase & Co. now owns 38,433,688 shares of the company’s stock valued at $1,530,815,000 after buying an additional 3,530,969 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of MetLife by 0.6% in the first quarter. Wellington Management Group LLP now owns 34,882,341 shares of the company’s stock valued at $1,532,730,000 after buying an additional 218,299 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of MetLife by 6.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 28,238,925 shares of the company’s stock valued at $1,124,756,000 after buying an additional 1,684,097 shares during the last quarter. Hedge funds and other institutional investors own 74.81% of the company’s stock.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.